We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GAO Flags Variations in FDA Comments to Generic Drug Applicants
GAO Flags Variations in FDA Comments to Generic Drug Applicants
The FDA should look into inconsistencies in its written comments to generic drug applicants to improve approval rates, the Government Accountability Office (GAO) says in a report released Wednesday.